Dapalina Tab

Dapalina Tab

Product Showcase
Dapalina Tab
Dapalina Tab

Information

Dapalina Tab is an incrementally modified drug, combining an SGLT2 inhibitor (Dapagliflozin) and a DPP4 inhibitor (Linagliptin), providing strong blood glucose control with just one daily dose. It is also expected to aid in weight loss and cardiovascular protection, with proven efficacy and safety in phase I, II and III clinical trials.
AJU PHARM CO.,LTDD28Aju Pharm was established in 1953 and specializes in the research and development of Incrementally Modified Drugs (IMDs) for chronic diseases. The company has built a comprehensive product portfolio covering various therapeutic areas, including hypertension, urology, and diabetes, while continuously investing in the innovation and development of new products.

Log in

See all the content and easy-to-use features by logging in or registering!